What is the Shattuck Labs Inc. stock price forecast?

Shattuck Labs Inc. is currently trading at $4.33. View real-time AI analysis on Alpha Lenz.

What is Shattuck Labs Inc. insider trading activity?

View the latest insider trading data for Shattuck Labs Inc. on Alpha Lenz.

What is Shattuck Labs Inc.'s P/E ratio?

View Shattuck Labs Inc.'s valuation metrics on Alpha Lenz.

Shattuck Labs Inc.

NASDAQ · STTK

$4.33-0.30(-6.48%)Pre-market

Ask about Shattuck Labs Inc.'s future dividend policy...

Alpha Chat Insight

“Shattuck Labs Inc.'s ROE is -60.3%. Explore profitability and growth together.”

Ask for details →

Company Overview

Shattuck Labs Inc. is a biopharmaceutical company focused on developing novel biologic therapies for cancer and autoimmune diseases. The company's proprietary platform, known as Agonist Redirected Checkpoint (ARC), is designed to harness the immune system's power to fight diseases by engaging both T cells and antigen-presenting cells simultaneously. This dual engagement aims to enhance the immune response against tumors and reduce immunological side effects. Operating within the biotechnology sector, Shattuck Labs Inc. is at the forefront of research and development, emphasizing innovative approaches to treat complex conditions. Its clinical-stage pipeline includes several candidates targeting various cancer types, offering potential advantages over existing therapies. Shattuck Labs emphasizes partnerships and collaborations to advance its therapeutic innovations, making it a significant player in the evolving landscape of immunotherapy development.

CEODr. Taylor H. Schreiber M.D., Ph.D.

Websitehttps://www.shattucklabs.com

SectorHealthcare

IndustryBiotechnology

Employees44

Company Statistics

FY 2025

Profile

N/AMarket Cap

$1.00MRevenue

0.00Shares Out

44Employees

Margins

N/AGross

-4782.00%EBITDA

-5150.80%Operating

-4880.90%Pre-Tax

-4880.90%Net

Valuation

N/AP/E

N/AP/B

N/AEV/Sales

N/AEV/EBITDA

N/AP/FCF

Growth (CAGR)

15.32%Rev 3Yr

-36.82%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-53.61%ROA

-60.25%ROE

-56.58%ROIC

Financial Health

$54.19MCash & Cash Equivalents

$-45.56MNet Debt

10.48%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Shattuck Labs Inc.'s ROE is -60.3%. Explore profitability and growth together.”

Ask for details →

Frequently Asked Questions

Shattuck Labs Inc. (ticker: STTK) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 44 employees.

The current price is $4.33 with a P/E ratio of -x and P/B of -x.

ROE is -60.25% and operating margin is -5150.80%. Annual revenue is $1M.